Last Updated : April 23, 2025
Details
| Call for patient/clinician input open | 06-Sep-24 |
|---|---|
| Call for patient/clinician input closed | 25-Nov-24 |
| Submission received | 18-Oct-24 |
| Submission accepted | 01-Nov-24 |
| Review initiated | 04-Nov-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 31-Jan-25 |
| Deadline for sponsors comments | 07-Feb-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 28-Feb-25 |
| Expert committee meeting (initial) | 12-Mar-25 |
| Draft recommendation issued to sponsor | 25-Mar-25 |
| Draft recommendation posted for stakeholder feedback | 03-Apr-25 |
| End of feedback period | 17-Apr-25 |
| Final recommendation issued to sponsor and drug plans | 01-May-25 |
| Final recommendation posted | - |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 15-May-25 |
| CDA-AMC review report(s) posted | - |